Your browser doesn't support javascript.
loading
MiR-4270 acts as a tumor suppressor by directly targeting Bcl-xL in human osteosarcoma cells.
Veys, Clément; Boulouard, Flavie; Benmoussa, Abderrahim; Jammes, Manon; Brotin, Emilie; Rédini, Françoise; Poulain, Laurent; Gruchy, Nicolas; Denoyelle, Christophe; Legendre, Florence; Galera, Philippe.
Affiliation
  • Veys C; Normandie Univ., UNICAEN, BIOTARGEN, Caen, France.
  • Boulouard F; Normandie Univ., UNICAEN, BIOTARGEN, Caen, France.
  • Benmoussa A; Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Caen University Hospital, Caen, France.
  • Jammes M; Normandie Univ., UNICAEN, BIOTARGEN, Caen, France.
  • Brotin E; Research Center of the UHC Sainte-Justine and Department of Nutrition, Université de Montréal, Montréal, QC, Canada.
  • Rédini F; Normandie Univ., UNICAEN, BIOTARGEN, Caen, France.
  • Poulain L; Normandie Univ., UNICAEN, Federative Structure Normandie Oncology, US Platon, ImpedanCELL Platform, Caen, France.
  • Gruchy N; Normandie Univ., UNICAEN, INSERM U1086 ANTICIPE, Biology and Innovative Therapeutics for Ovarian Cancer (BioTICLA), Caen, France.
  • Denoyelle C; UNICANCER, Comprehensive Cancer Center F. Baclesse, Caen, France.
  • Legendre F; UMR 1238 Phy-Os "Bone Sarcomas and Remodeling of Calcified Tissues", INSERM, Nantes University, Nantes, France.
  • Galera P; Normandie Univ., UNICAEN, INSERM U1086 ANTICIPE, Biology and Innovative Therapeutics for Ovarian Cancer (BioTICLA), Caen, France.
Front Oncol ; 13: 1220459, 2023.
Article in En | MEDLINE | ID: mdl-37719019

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2023 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2023 Type: Article Affiliation country: France